Table 2.
Morphological characteristics
|
Radiological imaging tests
|
n
(%)
|
| Malignant | 7 (19.4) |
| Non-malignant | 29 (80.6) |
| Worrisome features on EUS | 18 (50) |
| EUS diagnosis | |
| Malignant | 4 (11.1) |
| BD-IPMN | 9 (25) |
| MD-IPMN | 14 (38.9) |
| MCN | 5 (13.9) |
| SCN | 4 (11.1) |
| Location | |
| Head | 21 (58.3) |
| Body | 15 (41.7) |
| Tail | 0 |
| Multifocal | 8 (22.9) |
| Size (mm) | 27 ± 15.5 |
| Size MPD > 3 mm | 11 (30.6) |
| Mural nodule | 8 (22.2) |
| Contrast enhancement pattern | |
| Hypo/iso-enhanced walls | 18 (54.5) |
| Hyperenhanced walls | 12 (36.4) |
| Mixed enhancement pattern | 3 (9.1) |
Quantitative variables are expressed as mean ± standard deviation. Quantitative variables are expressed as absolute values, and their proportions are in bracketed text. EUS: Endoscopic ultrasound; BD-IPMN: Branch duct intraductal papillary mucinous neoplasm; MD-IPMN: Main duct intraductal papillary mucinous neoplasm; MCN: Mucinous cystic neoplasm; SCN: Serous cystic neoplasm; MPD: Main pancreatic duct.